Procurement of Essential Pharmaceutical Supplies for Indian Army Healthcare

Work Description - NA

This tender, initiated by the Department of Military Affairs under the Ministry of Defence, with a bid number GEM/2026/B/7819939, seeks to procure a comprehensive range of pharmaceutical supplies for the Indian Army. The tender, officially dated 01-08-2026, will commence its bidding period on 01-08-2026 at 12:53 PM and conclude on 31-08-2026 at 1:00 PM. The Bill of Quantities (BOQ) is titled "ECHS GEM 14 DRUGS 2026 27" and encompasses a significant total quantity of 39,593 units across various critical medications. Specifically, the required items include Rivastigmine Patches in dosages of 4.6 mg and 9 mg, Rivastigmine Patches at 15 mg, a synergistic Syp L Carnosine 200 mg plus Docosahexaenoic Acid 125 mg (Vegetarian formulation), and combination tablets of Telmisartan 40 mg plus Hydrochlorothiazide 12.5 mg. Additionally, the tender specifies the procurement of Rituximab 500mg Injection. This procurement is crucial for the healthcare needs of personnel associated with the ECHS (Ex-Servicemen Contributory Health Scheme) program, managed by the Organisation Name, Indian Army, and administered through offices located in Kamrup.